1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.2.1 Inclusions and Exclusions
1.3 Market Scope
Figure 1 Amniotic Products Market Segmentation
1.3.1 Regions Considered
1.3.2 Years Considered
1.4 Currency Considered
1.5 Stakeholders
1.6 Limitations
1.7 Recession Impact
1.8 Summary of Changes
2 Research Methodology
2.1 Research Data
Figure 2 Amniotic Products Market: Research Design
2.2 Secondary Data
2.2.1 Secondary Sources
2.3 Primary Data
Figure 3 Primary Sources
2.3.1 Key Data from Primary Sources
2.3.2 Key Industry Insights
Figure 4 Breakdown of Primary Interviews: by Company Type, Designation, and Region
2.4 Market Size Estimation
Figure 5 Market Size Estimation: Bottom-Up Approach
2.4.1 Growth Forecast
Figure 6 CAGR Projections: Supply-Side Analysis
Figure 7 Top-Down Approach
2.5 Market Breakdown and Data Triangulation
Figure 8 Data Triangulation Methodology
2.6 Market Share Analysis
2.7 Research Assumptions
2.8 Research Limitations
2.9 Risk Assessment
2.10 Growth Rate Assumptions
2.11 Recession Impact Analysis
3 Executive Summary
Figure 9 Amniotic Products Market, by Type, 2023 Vs. 2028 (USD Million)
Figure 10 Amniotic Products Market, by Application, 2023 Vs. 2028 (USD Million)
Figure 11 Amniotic Products Market, by End-user, 2023 Vs. 2028 (USD Million)
Figure 12 Amniotic Products Market, by Region, 2023 Vs. 2028 (USD Million)
4 Premium Insights
4.1 Attractive Opportunities for Players in Amniotic Products Market
Figure 13 Growing Target Patient Population to Drive Market
4.2 Amniotic Products Market, by Type
Figure 14 Cryopreserved Amniotic Membranes Segment to Register Higher CAGR During Forecast Period
4.3 North America: Amniotic Products Market, by Type and Country
Figure 15 US Accounted for Largest Market Share in North America in 2022
4.4 Amniotic Products Market, by Country
Figure 16 US and UK to Register Highest Growth During Forecast Period
5 Market Overview
5.1 Introduction
Figure 17 Amniotic Products Market: Drivers, Opportunities, and Challenges
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growth in Target Patient Population
Table 1 Global Prevalence of Diabetes
5.2.1.2 Rising Incidence of Burn Injuries and Increasing Number of Traumatic Wounds
5.2.1.3 Wound Care Awareness Programs and Increasing Funding for Wound Care Treatment and Management
Table 2 Wound Care Awareness Initiatives
Table 3 Funding for Regenerative Medicine Research by Nih Under 21St Century Cures Act
Table 4 Funding Initiatives from Corporate Partnerships in 2022 (USD Million)
Table 5 Funding from Corporate Partnerships in 2021 (USD Million)
Figure 18 Articles Related to Amniotic Products Published During 2010-2021
5.2.1.4 Increasing Number of Amniotic Membrane Transplantations
Table 6 Number of Amniotic Membrane Transplantations Performed in University Eye Hospital Tübingen, Germany
5.2.1.5 Increasing Number of Ophthalmology, Cosmetic, and Orthopedic Surgeries
5.2.1.6 Strategic Collaborations and Partnerships
5.2.1.7 Favorable Reimbursement Policies
Table 7 Medicare Allowable Amounts (USD)
5.2.2 Opportunities
5.2.2.1 Untapped Opportunities in Emerging Economies
Table 8 Strategic Developments in Asia-Pacific
5.2.2.2 Implementation of 21St Century Cures Act (Us)
5.2.2.3 Increasing Demand for Stem Cell Research and Regenerative Medicine
Figure 19 Stem Cell Research Funding from 2011 to 2020
Table 9 Nih Funding for Cell-Based Research, 2016-2021 (USD Million)
5.2.3 Challenges
5.2.3.1 Complications and Limitations Associated with Use of Amniotic Membranes
5.2.3.2 Ethical and Legal Concerns of Using Amniotic Membranes
5.2.3.3 High Cost of Amniotic Membrane Products
5.2.3.4 Competition from Alternative Therapies
5.2.4 Trends
5.2.4.1 Increasing Clinical Trials for Stem Cell and Chimeric Antigen Receptor-T Cell Therapies
5.2.4.2 Expanding Applications and Rising Focus on Standardization and Regulation of Amniotic Products
5.3 Trends/Disruptions Impacting Customer Business
5.3.1 Revenue Shift and Revenue Pockets for Amniotic Product Manufacturers
5.3.2 Revenue Shift in Amniotic Products Market
5.4 Pricing Analysis
Table 10 Prices of Amniotic Products
5.5 Supply Chain Analysis
Figure 20 Direct Distribution: Strategy Preferred by Prominent Companies
5.6 Value Chain Analysis
Figure 21 Value Chain Analysis: Major Value-Added During Development Phase
5.7 Ecosystem Analysis
5.7.1 Role in Ecosystem
Table 11 Role of Key Players in Ecosystem
Figure 22 Key Players in Amniotic Products Ecosystem
5.8 Technology Analysis
5.9 Patent Analysis
5.10 Trade Analysis
Table 12 Import Data for Extracts of Glands or Other Organs or of Their Secretions for Organo-Therapeutic Use, by Country, 2018-2022 (USD Thousand)
Table 13 Export Data for Extracts of Glands or Other Organs or of Their Secretions for Organo-Therapeutic Use, by Country, 2018-2022 (USD Thousand)
5.11 Regulatory Landscape
5.11.1 North America
5.11.2 Europe
5.11.3 Emerging Economies
5.12 Porter's Five Forces Analysis
Table 14 Amniotic Products Market: Impact of Porter's Five Forces
5.12.1 Intensity of Competitive Rivalry
5.12.2 Bargaining Power of Suppliers
5.12.3 Bargaining Power of Buyers
5.12.4 Threat of Substitutes
5.12.5 Threat of New Entrants
6 Amniotic Products Market, by Type
6.1 Introduction
6.2 Amniotic Membranes
Table 15 Amniotic Membranes Market, by Type, 2021-2028 (USD Million)
6.2.1 Cryopreserved Amniotic Membranes
6.2.1.1 Cryopreserved Amniotic Membranes to Dominate Amniotic Membranes Market During Forecast Period
Table 16 Cryopreserved Amniotic Membranes Market, by Region, 2021-2028 (USD Million)
6.2.2 Dehydrated Amniotic Membranes
6.2.2.1 Logistical Advantages of Dehydrated Amniotic Membranes Over Cryopreserved Amniotic Membranes to Drive Demand
Table 17 Dehydrated Amniotic Membranes Market, by Region, 2021-2028 (USD Million)
7 Amniotic Products Market, by Application
7.1 Introduction
7.2 Primary Notes
Table 18 Amniotic Products Market, by Application, 2021-2028 (USD Million)
7.3 Wound Care
7.3.1 Rising Incidence of Ulcers, Traumatic and Surgical Wounds, and Burns to Drive Market
Table 19 Amniotic Products Market for Wound Care, by Region, 2021-2028 (USD Million)
7.4 Orthopedics
7.4.1 Benefits Offered by Amniotic Products for Orthopedic Applications to Drive Market
Table 20 Amniotic Products Market for Orthopedics, by Region, 2021-2028 (USD Million)
7.5 Ophthalmology
7.5.1 Lightweight, Thin, and Elastic Nature of Amniotic Membranes to Drive Demand in Ophthalmology
Table 21 Amniotic Products Market for Ophthalmology, by Region, 2021-2028 (USD Million)
7.6 Other Applications
Table 22 Estimated Number of Colorectal Cancer Cases and Deaths in US in 2020, by Age
Table 23 Amniotic Products Market for Other Applications, by Region, 2021-2028 (USD Million)
8 Amniotic Products Market, by End-user
8.1 Introduction
Table 24 Amniotic Products Market, by End-user, 2021-2028 (USD Million)
8.2 Hospitals & Ambulatory Surgery Centers
8.2.1 Increasing Number of Surgical Procedures to Drive Market
Table 25 Amniotic Products Market for Hospitals & Ascs, by Region, 2021-2028 (USD Million)
8.3 Other End-users
Table 26 Amniotic Products Market for Other End-users, by Region, 2021-2028 (USD Million)
9 Amniotic Products Market, by Region
9.1 Introduction
Table 27 Amniotic Products Market, by Region, 2021-2028 (USD Million)
9.2 North America
Figure 23 North America: Amniotic Products Market Snapshot
Table 28 North America: Amniotic Products Market, by Country, 2021-2028 (USD Million)
Table 29 North America: Amniotic Membranes Market, by Type, 2021-2028 (USD Million)
Table 30 North America: Amniotic Products Market, by Application, 2021-2028 (USD Million)
Table 31 North America: Amniotic Products Market, by End-user, 2021-2028 (USD Million)
9.2.1 Us
9.2.1.1 Growing Geriatric Population and High Prevalence of Chronic Wounds and Diabetes to Drive Market
Table 32 Us: Key Macro Indicators
Table 33 Us: Amniotic Membranes Market, by Type, 2021-2028 (USD Million)
Table 34 Us: Amniotic Products Market, by Application, 2021-2028 (USD Million)
Table 35 Us: Amniotic Products Market, by End-user, 2021-2028 (USD Million)
9.2.2 Canada
9.2.2.1 Rising Prevalence of Target Diseases to Drive Market
Table 36 Incidence of Diabetes in Canada, 2019 Vs. 2029
Table 37 Canada: Key Macro Indicators
Table 38 Canada: Amniotic Membranes Market, by Type, 2021-2028 (USD Million)
Table 39 Canada: Amniotic Products Market, by Application, 2021-2028 (USD Million)
Table 40 Canada: Amniotic Products Market, by End-user, 2021-2028 (USD Million)
9.2.3 Recession Impact on North America
9.3 Europe
Table 41 Europe: Healthcare Expenditure, by Country (% of GDP)
Table 42 Prevalence of Diabetes in Europe, 2019 Vs. 2045
Table 43 Europe: Amniotic Products Market, by Country, 2021-2028 (USD Million)
Table 44 Europe: Amniotic Membranes Market, by Type, 2021-2028 (USD Million)
Table 45 Europe: Amniotic Products Market, by Application, 2021-2028 (USD Million)
Table 46 Europe: Amniotic Products Market, by End-user, 2021-2028 (USD Million)
9.3.1 Germany
9.3.1.1 Increasing Incidence of Diabetes to Drive Market
Table 47 Germany: Key Macro Indicators
Table 48 Germany: Amniotic Membranes Market, by Type, 2021-2028 (USD Million)
Table 49 Germany: Amniotic Products Market, by Application, 2021-2028 (USD Million)
Table 50 Germany: Amniotic Products Market, by End-user, 2021-2028 (USD Million)
9.3.2 Uk
9.3.2.1 High Prevalence of Diabetes Activities to Drive Market
Table 51 Uk: Key Macro Indicators
Table 52 Uk: Amniotic Membranes Market, by Type, 2021-2028 (USD Million)
Table 53 Uk: Amniotic Products Market, by Application, 2021-2028 (USD Million)
Table 54 Uk: Amniotic Products Market, by End-user, 2021-2028 (USD Million)
9.3.3 France
9.3.3.1 Government Support to Drive Demand for Amniotic Products
Table 55 France: Key Macro Indicators
Table 56 France: Amniotic Membranes Market, by Type, 2021-2028 (USD Million)
Table 57 France: Amniotic Products Market, by Application, 2021-2028 (USD Million)
Table 58 France: Amniotic Products Market, by End-user, 2021-2028 (USD Million)
9.3.4 Rest of Europe
Table 59 Rest of Europe: Healthcare Expenditure, by Country, 2010 Vs. 2021 (% of GDP)
Table 60 Rest of Europe: Amniotic Membranes Market, by Type, 2021-2028 (USD Million)
Table 61 Rest of Europe: Amniotic Products Market, by Application, 2021-2028 (USD Million)
Table 62 Rest of Europe: Amniotic Products Market, by End-user, 2021-2028 (USD Million)
9.3.5 Recession Impact on Europe
9.4 Asia-Pacific
Figure 24 Asia-Pacific: Amniotic Products Market Snapshot
Table 63 Asia-Pacific: Amniotic Products Market, by Country, 2021-2028 (USD Million)
Table 64 Asia-Pacific: Amniotic Membranes Market, by Type, 2021-2028 (USD Million)
Table 65 Asia-Pacific: Amniotic Products Market, by Application, 2021-2028 (USD Million)
Table 66 Asia-Pacific: Amniotic Products Market, by End-user, 2021-2028 (USD Million)
9.4.1 China
9.4.1.1 Increasing Incidence of Diabetes and Growth in Geriatric Population to Drive Market
Table 67 China: Key Macro Indicators
Table 68 China: Amniotic Membranes Market, by Type, 2021-2028 (USD Million)
Table 69 China: Amniotic Products Market, by Application, 2021-2028 (USD Million)
Table 70 China: Amniotic Products Market, by End-user, 2021-2028 (USD Million)
9.4.2 Japan
9.4.2.1 Growing Geriatric Population to Drive Market
Table 71 Japan: Key Macro Indicators
Table 72 Japan: Amniotic Membranes Market, by Type, 2021-2028 (USD Million)
Table 73 Japan: Amniotic Products Market, by Application, 2021-2028 (USD Million)
Table 74 Japan: Amniotic Products Market, by End-user, 2021-2028 (USD Million)
9.4.3 Rest of Asia-Pacific
Table 75 Rest of Asia-Pacific: Diabetes Prevalence (% of Population Aged 20-79), by Country, 2021
Table 76 Rest of Asia-Pacific: Amniotic Membranes Market, by Type, 2021-2028 (USD Million)
Table 77 Rest of Asia-Pacific: Amniotic Products Market, by Application, 2021-2028 (USD Million)
Table 78 Rest of Asia-Pacific: Amniotic Products Market, by End-user, 2021-2028 (USD Million)
9.4.4 Recession Impact on Asia-Pacific
9.5 Latin America
9.5.1 Increasing Prevalence of Diabetes to Drive Market
Table 79 Latin America: Diabetes Prevalence (% of Population Aged 20-79), by Country, 2021
Table 80 Latin America: Amniotic Membranes Market, by Type, 2021-2028 (USD Million)
Table 81 Latin America: Amniotic Products Market, by Application, 2021-2028 (USD Million)
Table 82 Latin America: Amniotic Products Market, by End-user, 2021-2028 (USD Million)
9.6 Middle East & Africa
9.6.1 Growth in Healthcare Infrastructure and Government Initiatives to Drive Market
Table 83 Middle East & Africa: Diabetes Prevalence (% of Population Aged 20-79), by Country, 2021
Table 84 Middle East & Africa: Amniotic Membranes Market, by Type, 2021-2028 (USD Million)
Table 85 Middle East & Africa: Amniotic Products Market, by Application, 2021-2028 (USD Million)
Table 86 Middle East & Africa: Amniotic Products Market, by End-user, 2021-2028 (USD Million)
10 Competitive Landscape
10.1 Overview
10.2 Strategies Adopted by Key Players
Table 87 Overview of Strategies Adopted by Key Amniotic Product Market Players
10.3 Market Share Analysis, 2022
Table 88 Amniotic Products Market: Degree of Competition (2022)
10.4 Revenue Share Analysis, 2022
Figure 25 Amniotic Products Market: Revenue Analysis of Top Four Market Players, 2020-2022
10.5 Company Evaluation Quadrant
10.5.1 Stars
10.5.2 Emerging Leaders
10.5.3 Pervasive Players
10.5.4 Participants
Figure 26 Amniotic Products Market: Company Evaluation Matrix, 2022
10.6 Small and Medium-Sized Enterprise/Startup Evaluation Quadrant
10.6.1 Progressive Companies
10.6.2 Starting Blocks
10.6.3 Responsive Companies
10.6.4 Dynamic Companies
Figure 27 Amniotic Products Market: Small and Medium-Sized Enterprise/ Startup Evaluation Matrix, 2022
10.7 Competitive Benchmarking
Table 89 Amniotic Products Market: Detailed List of Key Small and Medium-Sized Enterprises/Startups
10.8 Competitive Scenario
10.8.1 Product Launches
Table 90 Product Launches
10.8.2 Deals
Table 91 Deals
10.8.3 Others
Table 92 Others
10.9 Company Footprint Analysis
Table 93 Company Footprint Analysis
Table 94 Company Product Footprint
Table 95 Company Regional Footprint
11 Company Profiles
(Business Overview, Products/Solutions/Services Offered, Recent Developments, Analyst's View (Key Strengths/Right to Win, Strategic Choices Made, Weakness/Competitive Threats)*
11.1 Key Players
11.1.1 Mimedx Group, Inc.
Table 96 Mimedx Group, Inc.: Company Overview
Figure 28 Mimedx Group, Inc.: Company Snapshot (2022)
11.1.2 Smith+Nephew
Table 97 Smith+Nephew: Company Overview
Figure 29 Smith+Nephew: Company Snapshot (2022)
11.1.3 Organogenesis Inc.
Table 98 Organogenesis Inc.: Company Overview
Figure 30 Organogenesis Inc.: Company Snapshot (2022)
11.1.4 Integra Lifesciences
Table 99 Integra Lifesciences: Company Overview
Figure 31 Integra Lifesciences: Company Snapshot (2022)
11.1.5 Stryker
Table 100 Stryker: Company Overview
Figure 32 Stryker: Company Snapshot (2022)
11.1.6 Applied Biologics
Table 101 Applied Biologics: Company Overview
11.1.7 Celularity Inc.
Table 102 Celularity Inc.: Company Overview
11.1.8 Corza Ophthalmology
Table 103 Corza Ophthalmology: Company Overview
11.1.9 Lucina Biosciences
Table 104 Lucina Biosciences: Company Overview
11.1.10 Next Biosciences
Table 105 Next Biosciences: Company Overview
11.1.11 Skye Biologics Holdings, LLC
Table 106 Skye Biologics Holdings, LLC: Company Overview
11.1.12 Surgenex
Table 107 Surgenex: Company Overview
11.2 Other Players
11.2.1 Biotissue
11.2.2 Ventris Medical, LLC
11.2.3 Stimlabs LLC
11.2.4 Vivex Biologics, Inc.
11.2.5 Lifecell
11.2.6 Nuvision Biotherapies Ltd
11.2.7 Genesis Biologics, Inc.
11.2.8 Surgilogix
11.2.9 Tides Medical
11.2.10 Orthofix US LLC
11.2.11 Allosource
11.2.12 Merakris Therapeutics, Inc.
11.2.13 Mtf Biologics
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, Analyst's View (Key Strengths/Right to Win, Strategic Choices Made, Weakness/Competitive Threats)* Might Not be Captured in Case of Unlisted Companies.
12 Appendix
12.1 Discussion Guide
12.2 Knowledgestore: The Subscription Portal
12.3 Customization Options
12.4 Related Reports
12.5 Author Details
